TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
CGEN

Compugen

Healthcare · Biotechnology

2.40$ +1.3% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Balance Sheet

Compugen (CGEN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 157 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CGEN
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
115 99 71 39 53 54 138 132 94 121 115 157
75 91 63 31 47 45 129 123 86 115 106 148
73 81 62 30 46 9.8 7.1 7.8 11 14 18 91
74 82 62 30 46 44 124 117 83 51 103 146
0.4 8.4 0.1 0.7 0.2 0.3 2.0 0.2 0.3 61 0.3 0.3
-1.0 -1.8 -2.1 -1.7 -1.3 -0.8 -119 -6.0 -73 – – –
2.7 6.0 6.0 4.6 3.4 5.6 4.5 3.9 3.4 – – –
8.9 9.4 7.6 9.4 16 15 19 25 16 56 60 54
6.6 6.9 4.7 6.2 10.0 6.8 11 17 12 26 20 23
2.9 – – 0.3 – 0.6 0.6 0.8 0.6 0.6 0.4 0.5
1.5 2.0 1.3 3.4 2.9 1.1 1.4 4.6 1.8 3.5 1.8 2.4
– – – – 3.0 – – – – – – –
106 90 64 29 37 38 120 107 78 66 55 103
-219 -239 -271 -308 -331 -358 -388 -422 -456 -475 -489 -453
48 50 51 51 55 64 80 84 87 88 90 94

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?